Generate a tailored SOP for Dr. Gustavo Angarita. Improve your application with a focused, well-structured draft.
Gustavo Angarita, MD, specializes in psychiatry with a focus on addiction psychiatry, particularly related to cocaine addiction. He is the director of the Yale Cocaine Research Clinic, the inpatient chief of the Clinical Neuroscience Research Unit, and serves as the medical director of the Forensic Drug Diversion Clinic. Dr. Angarita is dedicated to understanding and treating substance use disorders, with the aim of developing effective treatments for cocaine dependence. His research interests include the regulation of cocaine self-administration, validation of remote wireless sensor network technology for detecting cocaine use, and investigating the therapeutic effects of atypical stimulants on cocaine-induced sleep deficits. He received his medical degree from Universidad Militar Nueva Granada and completed a research fellowship in addictions at Harvard Medical School, followed by residency training in adult psychiatry at Yale University School of Medicine. Dr. Angarita is board certified in Addiction Psychiatry and has been actively involved in clinical research focused on innovative treatments for cocaine addiction.
Yale School of Medicine • New Haven, CT
Assistant professor in the Psychiatry department, involved in education and treatment related to addiction.
Yale Cocaine Research Clinic • New Haven, CT
Leads research and clinical initiatives in cocaine addiction.
Forensic Drug Diversion Clinic • New Haven, CT
Oversees medical and clinical aspects of drug diversion treatment.
Clinical Neuroscience Research Unit • New Haven, CT
Chief clinical responsibilities managing inpatients in the research unit.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.